SJM vs TCRX · rev $9.05B vs rev $2.0M
JM Smucker Company (SJM) versus Tscan Therapeutics Inc (TCRX) — a side-by-side from cached financials, not a winner call.
JM Smucker Company (SJM) is a packaged foods company listed on US.
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
Latest reported SJM revenue for 2026-04-30 was $9.05B. Net income was -$138.7M. Revenue was up 3.7% from 2025-04-30 to 2026-04-30. SJM currently screens at market cap $11.10B.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
SJM currently screens at market cap $11.10B. TCRX currently screens at market cap $62.1M.
Not investment advice. Open the SJM and TCRX stock pages for the full models.
Not investment advice.